U.S. Cannabis Testing Market Analysis

U.S. Cannabis Testing Market Analysis

In terms of technology, the U.S. cannabis testing market is categorized into chromatography and spectroscopy. The spectroscopy technology segment is expected to reach USD 1.2 billion by 2030. This is attributed to various benefits offered by spectroscopy technology, including real-time analysis, high throughput, and minimal requirements for sample preparation. In addition, it is relatively more economical than its counterpart, which is slated to accelerate the adoption of spectroscopy.
 

With respect to test type, the U.S. cannabis testing market is divided into pesticide screening, heavy metal testing, residual solvent screening, potency testing, terpene testing, and mycotoxin testing. The residual solvent screening segment is anticipated to capture nearly 14% revenue share by 2030 as a result of its significance in the analysis of highly concentrated forms of cannabis. A Residual Solvent Test (RST) detects harmful solvents, impurities, and other added odorants & chemicals that are present in super-concentrated forms of cannabis, which is increasing the uptake of the test.
 

Pacific Central cannabis testing market is estimated to grow at more than 10.5% CAGR over 2022-2030. Due to substantial demand for medical marijuana in states such as California and Oregon, along with favorable regulatory norms pertaining to cannabis testing in the states, the zone is speculated to maintain its dominance in the forthcoming years. Global cannabis testing industry is set to record lucrative growth at over 13.5% CAGR through 2032 attributed to the growing legalization of cannabis in several countries for medical purposes.